Risk factors for probable REM sleep behavior disorder

Neurology

Volumn 86, Issue 14, 2016, Pages 1306-1312

  Wong, Janice C ^a,b,c   Li, Junjuan ^d   Pavlova, Milena ^a,b   Chen, Shuohua ^d   Wu, Aiping ^d   Wu, Shouling ^d   Gao, Xiang ^e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HEBEI UNITED UNIVERSITY   (China)

^e PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; GLUCOSE; LIPID; LOW DENSITY LIPOPROTEIN;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLUE COLLAR WORKER; BODY MASS; CHINESE; CHINESE REM SLEEP BEHAVIOR DISORDER QUESTIONNAIRE HONG KONG; CHRONIC DISEASE; COAL MINING; COFFEE; DIABETES MELLITUS; EDUCATIONAL STATUS; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HEAD INJURY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PARASOMNIA; PHYSICAL ACTIVITY; PHYSICAL INACTIVITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX; SLEEP DISORDER ASSESSMENT; SMELLING DISORDER; SMOKING; SOCIAL STATUS; TASTE DISORDER; TEA; ADOLESCENT; CHINA; COHORT ANALYSIS; MIDDLE AGED; REM SLEEP BEHAVIOR DISORDER; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHINA; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; REM SLEEP BEHAVIOR DISORDER; RISK FACTORS; YOUNG ADULT;

EID: 84963595050     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002414     Document Type: Article

References (38)

1. Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, Montplaisir J. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2009;72:1296-1300.
2. Claassen DO, Josephs KA, Ahlskog JE, Silber MH, Tippmann-Peikert M, Boeve BF. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 2010;75:494-499.
3. Hickey MG, Demaerschalk BM, Caselli RJ, Parish JM, Wingerchuk DM. "Idiopathic" rapid-eye-movement (REM) sleep behavior disorder is associated with future development of neurodegenerative diseases. Neurologist 2007;13:98-101.
4. Postuma RB, Gagnon JF, Vendette M, Desjardins C, Montplaisir JY. Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann Neurol 2011;69:811-818.
5. Boot BP, Boeve BF, Roberts RO, et al. Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: a populationbased study. Ann Neurol 2012;71:49-56.
6. Postuma RB, Montplaisir JY, Pelletier A, et al. Environmental risk factors for REM sleep behavior disorder: a multicenter case-control study. Neurology 2012;79: 428-434.
7. Frauscher B, Jennum P, Ju YE, et al. Comorbidity and medication in REM sleep behavior disorder: a multicenter case-control study. Neurology 2014;82:1076-1079.
8. Postuma RB, Iranzo A, Hogl B, et al. Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol 2015; 77:830-839.
9. Zhang Q, Zhou Y, Gao X, et al. Ideal cardiovascular health metrics and the risks of ischemic and intracerebral hemorrhagic stroke. Stroke 2013;44:2451-2456.
10. Li SX, Wing YK, Lam SP, et al. Validation of a new REM sleep behavior disorder questionnaire (RBDQ-HK). Sleep Med 2010;11:43-48.
11. Shen SS, Shen Y, Xiong KP, et al. Validation study of REM sleep behavior disorder questionnaire-Hong Kong (RBDQ-HK) in east China. Sleep Med 2014; 15:952-958.
12. Hoffman HJ, Ishii EK, MacTurk RH. Age-related changes in the prevalence of smell/taste problems among the United States adult population: results of the 1994 disability supplement to the National Health Interview Survey (NHIS). Ann N Y Acad Sci 1998;855:716-722.
13. Schenck CH, Bundlie SR, Patterson AL, Mahowald MW. Rapid eye movement sleep behavior disorder: a treatable parasomnia affecting older adults. JAMA 1987;257:1786-1789.
14. Boeve BF, Silber MH, Parisi JE, et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 2003;61:40-45.
15. Wong JC, Hazrati LN. Parkinsons disease, parkinsonism, and traumatic brain injury. Crit Rev Clin Lab Sci 2013; 50:103-106.
16. Ross GW, Abbott RD, Petrovitch H, et al. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 2000;283:2674-2679.
17. Palacios N, Gao X, McCullough ML, et al. Caffeine and risk of Parkinsons disease in a large cohort of men and women. Mov Disord 2012;27:1276-1282.
18. Checkoway H, Powers K, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD. Parkinsons disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 2002;155:732-738.
19. Godwin-Austen RB, Lee PN, Marmot MG, Stern GM. Smoking and Parkinsons disease. J Neurol Neurosurg Psychiatry 1982;45:577-581.
20. Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinsons disease. Ann Neurol 2002;52:276-284.
21. Gorell JM, Rybicki BA, Johnson CC, Peterson EL. Smoking and Parkinsons disease: a dose-response relationship. Neurology 1999;52:115-119.
22. Ross GW, Petrovitch H, Abbott RD, et al. Association of olfactory dysfunction with risk for future Parkinsons disease. Ann Neurol 2008;63:167-173.
23. Postuma RB, Gagnon JF, Vendette M, Montplaisir JY. Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinsons disease. Brain 2009;132:3298-3307.
24. Shin HY, Joo EY, Kim ST, Dhong HJ, Cho JW. Comparison study of olfactory function and substantia nigra hyperechogenicity in idiopathic REM sleep behavior disorder, Parkinsons disease and normal control. Neurol Sci 2013;34:935-940.
25. Vendette M, Gagnon JF, Soucy JP, et al. Brain perfusion and markers of neurodegeneration in rapid eye movement sleep behavior disorder. Mov Disord 2011; 26:1717-1724.
26. Mahlknecht P, Iranzo A, Hogl B, et al. Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD. Neurology 2015;84:654-658.
27. Postuma RB, Gagnon JF, Bertrand JA, Genier Marchand D, Montplaisir JY. Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials. Neurology 2015;84:1104-1113.
28. Cecchini MP, Osculati F, Ottaviani S, Boschi F, Fasano A, Tinazzi M. Taste performance in Parkinsons disease. J Neural Transm 2014;121:119-122.
29. Kim HJ, Jeon BS, Lee JY, Cho YJ, Hong KS, Cho JY. Taste function in patients with Parkinson disease. J Neurol 2011;258:1076-1079.
30. Lang CJ, Leuschner T, Ulrich K, Stossel C, Heckmann JG, Hummel T. Taste in dementing diseases and parkinsonism. J Neurol Sci 2006;248:177-184.
31. Shah M, Deeb J, Fernando M, et al. Abnormality of taste and smell in Parkinsons disease. Parkinsonism Relat Disord 2009;15:232-237.
32. Lanfranchi PA, Fradette L, Gagnon JF, Colombo R, Montplaisir J. Cardiac autonomic regulation during sleep in idiopathic REM sleep behavior disorder. Sleep 2007;30: 1019-1025.
33. Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL. The effectiveness of exercise interventions for people with Parkinsons disease: a systematic review and meta-analysis. Mov Disord 2008;23:631-640.
34. Goodwin BL, Kite GC. Environmental MPTP as a factor in the aetiology of Parkinsons disease? J Neural Transm 1998;105:1265-1269.
35. Mulloy KB. Two case reports of neurological disease in coal mine preparation plant workers. Am J Ind Med 1996; 30:56-61.
36. Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 2000;123:331-339.
37. Zhang B, Wing YK. Sex differences in insomnia: a metaanalysis. Sleep 2006;29:85-93.
38. Kang SH, Yoon IY, Lee SD, Han JW, Kim TH, Kim KW. REM sleep behavior disorder in the Korean elderly population: prevalence and clinical characteristics. Sleep 2013; 36:1147-1152.